HAMBURG (dpa-AFX) - The private bank Berenberg has added Schott Pharma to its rating with a "Hold" and a target price of 38 euros. The specialty glass manufacturer for the pharmaceutical industry convinces with a high company quality, which, however, is already priced into the share price, analyst Victoria Lambert wrote in a study published on Wednesday. The packaging specialist is also benefiting from the boom in weight loss products and contracts with regard to mRNA vaccines. However, after the share price rise since the fall stock market rout, the company's outlook is reflected in the share price./mis/gl

Publication of the original study: 26.03.2024 / 17:49 / GMT First dissemination of the original study: Date not specified in study / Time not specified in study / Time zone not specified in study

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------